The consolidated revenue of Bafna Pharmaceuticals Ltd, manufacturer and exporter of drug formulation, rose by 62.45 per cent from Rs 4579.95 lakh to Rs 7440.14 lakh for the financial year ended March 31, 2010.
The net profit rose by 132.46 per cent from Rs 106.75 lakh to Rs 248.15 lakh for the fiscal year. While the profit before tax for the quarter was at Rs 91.71 lakh, the net sales was at Rs 2407.62 lakh thus presenting an impressive growth in the revenues by 36.56 per cent.
Commenting on the financial performance of the company, Bafna Mahaveer Chand, CMD, Bafna Pharmaceuticals Ltd says, “It has been a satisfying year, one in which we could achieve our goals sets towards customer satisfaction, quality standards and, of course shareholder value. We are confident that this will be a good platform to achieve our long term vision of dominating our product categories worldwide.”